A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.

Dissolution research started to develop about 100 years ago as a field of physical chemistry and since then important progress has been made. However, explicit interest in drug related dissolution has grown only since the realisation that dissolution is an important factor of drug bioavailability in the 1950s. This review attempts to account the most important developments in the field, from a historical point of view. It is structured in a chronological order, from the theoretical foundations of dissolution, developed in the first half of the 20th century, and the development of a relationship between dissolution and bioavailability in the 1950s, going to the more recent developments in the framework of the Biopharmaceutics Classification System (BCS). Research on relevant fields of pharmaceutical technology, like sustained release formulations, where drug dissolution plays an important role, is reviewed. The review concludes with the modern trends on drug dissolution research and their regulatory implications.

[1]  D E Wurster,et al.  Dissolution kinetics of certain crystalline forms of prednisolone. , 1965, Journal of pharmaceutical sciences.

[2]  H. Vromans,et al.  Biowaivers for Oral Immediate-Release Products , 2004, Clinical pharmacokinetics.

[3]  J. Cloyd,et al.  Reduced seizure control due to spoiled phenytoin capsules , 1980, Annals of neurology.

[4]  Jennifer B Dressman,et al.  Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  James C. Sexton,et al.  Computational fluid dynamics modeling of the paddle dissolution apparatus: Agitation rate, mixing patterns, and fluid velocities , 2004, AAPS PharmSciTech.

[6]  Gordon L. Amidon,et al.  Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model , 1993, Pharmaceutical Research.

[7]  Michael Weiss,et al.  Does the Dose-Solubility Ratio Affect the Mean Dissolution Time of Drugs? , 2004, Pharmaceutical Research.

[8]  Panos Macheras,et al.  Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics: Homogeneous and Heterogeneous Approaches , 2005 .

[9]  Panos Macheras,et al.  Gastrointestinal Drug Absorption: Is It Time to Consider Heterogeneity as Well as Homogeneity? , 1997, Pharmaceutical Research.

[10]  S. Pedersen,et al.  Erratic absorption of a slow-release theophylline sprinkle product. , 1984, Pediatrics.

[11]  Michael A. Koupparis,et al.  Dissolution of 4 controlled-release theophylline formulations in milk , 1987 .

[12]  G. Amidon,et al.  Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. , 2004, Molecular pharmaceutics.

[13]  E NELSON,et al.  Inactive prednisone tablets U.S.P. XVI. , 1963, Journal of pharmaceutical sciences.

[14]  Vinod P. Shah,et al.  Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions , 2002, Pharmaceutical Research.

[15]  Alexander T. Florence,et al.  Solubilization by surface-active agents and its applications in chemistry and the biological sciences , 1968 .

[16]  P. Pentikäinen,et al.  Effect of particle size on the bioavailability of digoxin , 1975, European Journal of Clinical Pharmacology.

[17]  W. L. Chiou,et al.  Mechanism of increased rates of dissolution and oral absorption of chloramphenicol from chloramphenicol-urea solid dispersion system. , 1971, Journal of pharmaceutical sciences.

[18]  P. Maturu,et al.  Influence of a high fat breakfast on the bioavailability of theophylline controlled-release formulations: an in vitro demonstration of an in vivo observation. , 1986, Journal of pharmaceutical sciences.

[19]  Walter Schmitt,et al.  A physiological model for the estimation of the fraction dose absorbed in humans. , 2004, Journal of medicinal chemistry.

[20]  W. G. Lloyd,et al.  Diffusion in glassy polymers , 2007 .

[21]  Sophia G. Antimisiaris,et al.  An in vitro model for exploring CR theophylline-milk fat interactions , 1989 .

[22]  E NELSON,et al.  Solution rate of theophylline salts and effects from oral administration. , 1957, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[23]  K. Kosmidis,et al.  On the use of the Weibull function for the discernment of drug release mechanisms. , 2006, International journal of pharmaceutics.

[24]  Mei-Ling Chen,et al.  Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunities. , 2004, Journal of pharmaceutical sciences.

[25]  G. Levy,et al.  Effect of particle size on dissolution and gastrointestinal absorption rates of pharmaceuticals. , 1963, American journal of pharmacy and the sciences supporting public health.

[26]  Panos Macheras,et al.  The Mean Dissolution Time Depends on the Dose/Solubility Ratio , 2003, Pharmaceutical Research.

[27]  W. Schmitt,et al.  A Physiologic Model for Simulating Gastrointestinal Flow and Drug Absorption in Rats , 2003, Pharmaceutical Research.

[28]  D C Hohnadel,et al.  Effect of calcium and antacids on phenytoin bioavailability. , 1979, Archives of neurology.

[29]  A B Varley,et al.  The generic inequivalence of drugs. , 1968, JAMA.

[30]  V. T. Stannett,et al.  Effect of particle size on the mechanism controlling n-hexane sorption in glassy polystyrene microspheres , 1977 .

[31]  P. V. Danckwerts Significance of Liquid-Film Coefficients in Gas Absorption , 1951 .

[32]  L. J. Edwards The dissolution and diffusion of aspirin in aqueous media , 1951 .

[33]  G. Amidon,et al.  Absorption potential: estimating the fraction absorbed for orally administered compounds. , 1985, Journal of pharmaceutical sciences.

[34]  Anette Müllertz,et al.  Dissolution of Hydrocortisone in Human and Simulated Intestinal Fluids , 2000, Pharmaceutical Research.

[35]  Juergen Siepmann,et al.  A New Mathematical Model Quantifying Drug Release from Bioerodible Microparticles Using Monte Carlo Simulations , 2002, Pharmaceutical Research.

[36]  Ajaz S. Hussain,et al.  The Effect of In Vivo Dissolution, Gastric Emptying Rate, and Intestinal Transit Time on the Peak Concentration and Area-Under-the-Curve of Drugs with Different Gastrointestinal Permeabilities , 2004, Pharmaceutical Research.

[37]  A. Noyes,et al.  The rate of solution of solid substances in their own solutions , 1897 .

[38]  Susumu Miyamoto,et al.  A theory of the rate of solution of solid into liquid , 1932 .

[39]  V. Shah,et al.  Phenytoin II: in vitro-in vivo bioequivalence standard for 100-mg phenytoin sodium capsules. , 1983, Journal of pharmaceutical sciences.

[40]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[41]  Vinod P. Shah,et al.  Importance of media selection in establishment of in vitro-in vivo relationships for quinidine gluconate , 1982 .

[42]  Michael Levin Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System , 2001 .

[43]  Panos Macheras,et al.  Quantitative Biopharmaceutics Classification System: The Central Role of Dose/Solubility Ratio , 2003, Pharmaceutical Research.

[44]  L Hendeles,et al.  Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity. , 1985, Chest.

[45]  Shlomo Havlin,et al.  On controlled diffusion‐limited drug release from a leaky matrix , 1985 .

[46]  F Langenbucher,et al.  Letters to the Editor: Linearization of dissolution rate curves by the Weibull distribution , 1972, The Journal of pharmacy and pharmacology.

[47]  Harold Boxenbaum,et al.  Absorption Potential and Its Variants , 1999, Pharmaceutical Research.

[48]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[49]  Meyer Wildermann,et al.  Über die Geschwindigkeit molekularer und chemischer Reaktionen in heterogenen Systemen. Erster Teil. , 1909 .

[50]  Mehran Yazdanian,et al.  The “High Solubility” Definition of the Current FDA Guidance on Biopharmaceutical Classification System May Be Too Strict for Acidic Drugs , 2004, Pharmaceutical Research.

[51]  T. Higuchi,et al.  Rate of release of medicaments from ointment bases containing drugs in suspension. , 1961, Journal of pharmaceutical sciences.

[52]  Samuel H. Yalkowsky,et al.  A Simple Modified Absorption Potential , 2001, Pharmaceutical Research.

[53]  F. Bochner,et al.  Factors involved in an outbreak of phenytoin intoxication. , 1972, Journal of the neurological sciences.

[54]  M. Mellow,et al.  Variation in biologic availability of digoxin from four preparations. , 1971, The New England journal of medicine.

[55]  M. Eadie,et al.  Outbreak of Anticonvulsant Intoxication in an Australian City* , 1970, British medical journal.

[56]  Hans Lennernäs,et al.  The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids , 2005, Pharmaceutical Research.

[57]  Christos Reppas,et al.  Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.

[58]  A. Healy,et al.  Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability , 2005, The Journal of pharmacy and pharmacology.

[59]  M. Gibaldi,et al.  Rate of Dissolution of Griseofulvin and Hexoestrol in Bile Salt Solutions , 1966, Nature.

[60]  C. Hagemeir,et al.  A unified mathematical model for diffusion from drug-polymer composite tablets. , 1976, Journal of biomedical materials research.

[61]  Erich Brunner,et al.  Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .

[62]  J. M. Cook,et al.  The fractal approach to heterogeneous chemistry , 1990 .

[63]  Panos Macheras,et al.  Identification of Biowaivers Among Class II Drugs: Theoretical Justification and Practical Examples , 2004, Pharmaceutical Research.

[64]  R. Löbenberg,et al.  Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.

[65]  G LEVY EFFECT OF DOSAGE FORM PROPERTIES ON THERAPEUTIC EFFICACY OF TOLBUTAMIDE TABLETS. , 1964, Canadian Medical Association journal.

[66]  N. Peppas Analysis of Fickian and non-Fickian drug release from polymers. , 1985, Pharmaceutica acta Helvetiae.

[67]  W. Nernst,et al.  Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .

[68]  D. F. Evans,et al.  Accelerating gallstone dissolution. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[69]  L. Bruner,et al.  Über die Auflösungsgeschwindigkeit fester Körper , 1900 .

[70]  J. Ruedy,et al.  Comparative bioavailability of three brands of ampicillin. , 1972, Canadian Medical Association journal.

[71]  D E WURSTER,et al.  Investigation of drug release from solids. IV. Influence of adsorption on the dissolution rate. , 1961, Journal of pharmaceutical sciences.

[72]  Gerhard Levy,et al.  Studies on Inactive Prednisone Tablets, U.S.P. XVI , 1964 .

[73]  M Gibaldi,et al.  Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. , 1967, Journal of pharmaceutical sciences.

[74]  Vinod P. Shah,et al.  In Vitro Topographical Characterization as a Predictor of in Vivo Controlled Release Quinidine Gluconate Bioavailability , 1986 .

[75]  Anne Marie Healy,et al.  Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics--dissolution rate implications. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[76]  Lutz Trahms,et al.  Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. , 2005, Advanced drug delivery reviews.

[77]  E. Rinaki,et al.  The power law can describe the 'entire' drug release curve from HPMC-based matrix tablets: a hypothesis. , 2003, International journal of pharmaceutics.

[78]  J. W. Poston,et al.  BIOAVAILABILITY OF DIGOXIN , 1972 .

[79]  A. Dokoumetzidis,et al.  Analysis of Dissolution Data Using Modified Versions of Noyes–Whitney Equation and the Weibull Function , 2006, Pharmaceutical Research.

[80]  F Theeuwes,et al.  Dosage form index: an objective criterion for evaluation of controlled-release drug delivery systems. , 1977, Journal of pharmaceutical sciences.

[81]  J. H. G. Jonkman,et al.  Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet , 2004, European Journal of Clinical Pharmacology.

[82]  J. Siepmann,et al.  Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). , 2001 .

[83]  P. Macheras,et al.  Toward a quantitative approach for the prediction of the fraction of dose absorbed using the absorption potential concept. , 1989, Biopharmaceutics & drug disposition.

[84]  Blythe Rh,et al.  The formulation and evaluation of enteric coated aspirin tablets. , 1959 .

[85]  S. Pedersen,et al.  Delay in the absorption rate of theophylline from a sustained release theophylline preparation caused by food. , 1981, British journal of clinical pharmacology.

[86]  A. B. Morrison,et al.  TABLET DISINTEGRATION AND PHYSIOLOGICAL AVAILABILITY OF DRUGS. , 1965, Journal of pharmaceutical sciences.

[87]  Panos Macheras,et al.  Fractal kinetics in drug release from finite fractal matrices , 2003 .

[88]  James C. Sexton,et al.  Simulating the hydrodynamic conditions in the united states pharmacopeia paddle dissolution apparatus , 2008, AAPS PharmSciTech.

[89]  A. W. Hixson,et al.  Dependence of Reaction Velocity upon surface and Agitation , 1931 .

[90]  Panos Macheras,et al.  A Reappraisal of Drug Release Laws Using Monte Carlo Simulations: The Prevalence of the Weibull Function , 2003, Pharmaceutical Research.

[91]  J. Siepmann,et al.  Effect of the size of biodegradable microparticles on drug release: experiment and theory. , 2004, Journal of controlled release : official journal of the Controlled Release Society.